A backlog of referrals for suspected melanoma has grown hugely during the pandemic, adding to an already overwhelmed pathway. The vast majority of referred lesions turn out to be benign. Yet, there is an urgent need for a ‘rule-out’ test to focus resources through early reassurance of cases with no evidence of melanoma. Unlike the …

by Francesco Condello